Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Generalized Pustular Psoriasis and Erythrodermic Psoriasis”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Large-scale testing (Phase 3)Study completedNCT03022045
What this trial is testing

Assess Efficacy and Safety of Two Different Dose Regimens of Risankizumab Administered Subcutaneously in Japanese Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Psoriasis
AbbVie 18
Large-scale testing (Phase 3)Active Not RecruitingNCT06323356
What this trial is testing

TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Takeda 18
Post-approval studies (Phase 4)Study completedNCT03942042
What this trial is testing

Ixekizumab (LY2439821) in Participants in Japan With Generalized Pustular Psoriasis and Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Eli Lilly and Company 12
Not applicableStudy completedNCT03885089
What this trial is testing

Infliximab Biosimilar for Intravenous Drip Infusion 100 mg "Pfizer" Drug Use Investigation (Psoriasis)

Who this might be right for
Psoriasis VulgarisPsoriasis ArthropathicaPustular Psoriasis+1 more
Pfizer 10
Large-scale testing (Phase 3)Study completedNCT02343744
What this trial is testing

An Efficacy and Safety Study of CNTO1959 (Guselkumab) in the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Pustular Psoriasis
Janssen Pharmaceutical K.K. 21
Large-scale testing (Phase 3)Study completedNCT03051217
What this trial is testing

Test the Efficacy and Safety of Certolizumab Pegol in Japanese Subjects With Moderate to Severe Chronic Psoriasis

Who this might be right for
Moderate to Severe PsoriasisGeneralized Pustular Psoriasis and Erythrodermic Psoriasis
UCB Biopharma S.P.R.L. 127
Large-scale testing (Phase 3)Active Not RecruitingNCT06295692
What this trial is testing

JNJ-77242113 for the Treatment of Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Who this might be right for
Generalized Pustular PsoriasisErythrodermic Psoriasis
Janssen Pharmaceutical K.K. 19
Not applicableActive Not RecruitingNCT06952465
What this trial is testing

A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis

Who this might be right for
Psoriasis
Bristol-Myers Squibb 2,000